Enveric Biosciences

$Enveric Biosciences(ENVB)$ 绝地反击？还是怎么 获得美国专利商标局神经精神药物专利批准

$Enveric Biosciences(ENVB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-120055  Act: 34  Size: 9 KB 网页链接

$Enveric Biosciences(ENVB)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-26-001151  Act: 34  Size: 9 MB 网页链接

$Enveric Biosciences(ENVB)$ 8-K Current report, item 8.01 Accession Number: 0001493152-25-023444  Act: 34  Size: 199 KB 网页链接

$Enveric Biosciences(ENVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-337179  Size: 5 KB 网页链接

$Enveric Biosciences(ENVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-337172  Size: 5 KB 网页链接

$Enveric Biosciences(ENVB)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-123020  Act: 34  Size: 18 KB 网页链接

$Enveric Biosciences(ENVB)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-26-005606  Act: 34  Size: 243 KB 网页链接

$Enveric Biosciences(ENVB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-120056  Act: 34  Size: 8 KB 网页链接

$Enveric Biosciences(ENVB)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001493152-25-027541  Act: 34  Size: 854 KB 网页链接

$Enveric Biosciences(ENVB)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001493152-25-027196  Act: 34  Size: 225 KB 网页链接

$Enveric Biosciences(ENVB)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-25-028623  Act: 33  Size: 286 KB 网页链接

$Enveric Biosciences(ENVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-023540  Act: 34  Size: 4 MB 网页链接

$Enveric Biosciences(ENVB)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493152-25-022260  Act: 34  Size: 11 KB 网页链接

$Enveric Biosciences(ENVB)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-25-029801  Act: 33  Size: 325 KB 网页链接

$Enveric Biosciences(ENVB)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-026451  Act: 33  Size: 440 KB 网页链接

$Enveric Biosciences(ENVB)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-118884  Act: 34  Size: 8 KB 网页链接

$Enveric Biosciences(ENVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003576  Act: 33  Size: 1 KB 网页链接

$Enveric Biosciences(ENVB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000929638-26-000009  Act: 34  Size: 6 KB 网页链接

$Enveric Biosciences(ENVB)$ 该文件报告称，截至2025年12月17日，Intracoastal Capital, LLC以及个人Mitchell P. Kopin和Daniel B. Asher可能被视为实益拥有Enveric Biosciences, Inc.普通股31,353股。这一持股比例约占已发行普通股的4.99%。此所有权主要源于可行使Intracoastal Warrant 1而发行...